RA Capital Management - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q2 2022$61,311,000
-14.6%
9,003,0180.0%1.64%
+4.4%
Q1 2022$71,754,000
+42.3%
9,003,0180.0%1.57%
+76.2%
Q4 2021$50,417,000
-26.0%
9,003,018
+1.7%
0.89%
-5.8%
Q3 2021$68,103,0008,856,0180.94%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,383,029$24,594,6214.83%
Velan Capital Investment Management LP 494,136$3,592,3693.06%
BVF INC/IL 10,563,748$76,798,4482.81%
JOHNSON & JOHNSON 1,000,000$7,270,0002.36%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,925,7071.16%
PFM Health Sciences, LP 3,204,790$23,298,8231.03%
Pier Capital, LLC 862,736$6,272,0910.95%
Boxer Capital, LLC 2,500,000$18,1750.89%
Deep Track Capital, LP 2,345,073$17,048,6810.70%
SILVERARC CAPITAL MANAGEMENT, LLC 198,477$1,442,9280.60%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders